1. [PDF] COVID-19 seropositivity changes in asymptomatic individuals during the ...
27 jan 2021 · Soon after our cohort SPR reached. 40 %, the second wave peaked without imposing strict "lockdown" measures. ... Kazutaka Hayashida, MD, Ph.D.
2. [PDF] Dynamic Change of COVID-19 Seroprevalence among ... - medRxiv
23 sep 2020 · Seroprevalence increased from 5.8 % to. 46.8 % over the course of the summer. The most dramatic increase in SPR occurred in late June and early ...
3. [PDF] Dynamic change of COVID-19 seroprevalence among ...
8 jun 2021 · Kazutaka Hayashida ( kazutaka.hayashida@childrens.harvard.edu ). Boston Children's Hospital. Andrew C Ahn. Beth Israel Deaconess Medical ...
4. Modifiable Host Factors for the Prevention and Treatment of COVID ...
Kazutaka Hayashida Received 2022 Mar 9; Accepted 2022 Apr 24; Collection date 2022 May. Licensee MDPI, Basel, Switzerland.
Many studies have shown that the immune system requires adequate nutrition to work at an optimal level. Not only do optimized nutritional strategies support the immune system, but they also reduce chronic inflammation. Nutritional supplements that ...
5. Heparan sulfate 3-O-sulfotransferase 4 is genetically associated with ...
Among HZ-afflicted patients, 27–73% develop PHN, which is age-dependent. ... Hayashida, Kazutaka Ikeda. Formal analysis: Seii Ohka. Funding acquisition ...
Acute pain that is associated with herpes zoster (HZ) can become long-lasting neuropathic pain, known as chronic post-herpetic neuralgia (PHN), especially in the elderly. HZ is caused by the reactivation of latent varicella-zoster virus (VZV), ...
6. Role of HSPGs in Systemic Bacterial Infections. - Abstract - Europe PMC
1 jan 2022 · Role of HSPGs in Systemic Bacterial Infections. Rafael S. Aquino,1 Kazutaka Hayashida ... Mice: Mice are generally used at the age of 5–12 weeks ( ...
Europe PMC is an archive of life sciences journal literature.
7. [PDF] arXiv:1711.07727v1 [astro-ph.HE] 21 Nov 2017
21 nov 2017 · ously assumed despite over 40 years of detailed study. Thus ... Hayashida provided key comments on the whole discussion. He also made ...
8. [PDF] Nummer 45/15 04 november 2015
4 nov 2015 · ... (40). (41). (42). (43). Patent number. Kind of document code according to ... Kazutaka. KOGA, Nobuyoshi. TSUCHIMOCHI, Yukiko. (31) 2008034993.
9. Lectin-like oxidized LDL receptor-1 (LOX-1) expression is ... - OUCI
Publications that cite this publication. Ox-LDL increases OX40L ... Noriaki Kume, Hirokazu Mitsuoka, Kazutaka Hayashida, Masaru Tanaka, Goro Kominami, Toru Kita.
https://doi.org/10.1016/j.atherosclerosis.2006.11.031 ·
